Astria Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Astria Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Astria Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Astria Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $104k | 14k | 7.68 |
| 2023-09-30 | $314k | 42k | 7.46 |
| 2023-06-30 | $439k | 53k | 8.33 |
| 2023-03-31 | $499k | 38k | 13.30 |
| 2022-12-31 | $263k | 18k | 14.89 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management